MarketBeat Instant News Alerts 2 hours agoAlumis Inc. (NASDAQ:ALMS) Receives Average Rating of "Buy" from AnalystsMarketBeatShares of Alumis Inc. (NASDAQ:ALMS - Get Free Report) have been given an average rating of "Buy" by the eight ratings firms that are covering the firm, MarketBeat.com reports. Seven investment analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. NASDAQ:ALMSRead Alumis Inc. (NASDAQ:ALMS) Receives Average Rating of "Buy" from Analysts2 hours agoNVR, Inc. (NYSE:NVR) Receives Average Recommendation of "Hold" from BrokeragesMarketBeatNVR, Inc. (NYSE:NVR - Get Free Report) has been given a consensus rating of "Hold" by the four ratings firms that are currently covering the firm, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The aNYSE:NVRRead NVR, Inc. (NYSE:NVR) Receives Average Recommendation of "Hold" from Brokerages2 hours agoUrogen Pharma (NASDAQ:URGN) Receives Consensus Rating of "Buy" from AnalystsMarketBeatUrogen Pharma (NASDAQ:URGN - Get Free Report) has received a consensus rating of "Buy" from the nine analysts that are presently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a hold rating, seven have assigned a buy rating and one has given a strong NASDAQ:URGNRead Urogen Pharma (NASDAQ:URGN) Receives Consensus Rating of "Buy" from Analysts2 hours agoSight Sciences, Inc. (NASDAQ:SGHT) Receives Consensus Rating of "Hold" from AnalystsMarketBeatSight Sciences, Inc. (NASDAQ:SGHT - Get Free Report) has been assigned a consensus recommendation of "Hold" from the seven research firms that are covering the stock, Marketbeat Ratings reports. Four equities research analysts have rated the stock with a hold rating and three have given a buy ratinNASDAQ:SGHTRead Sight Sciences, Inc. (NASDAQ:SGHT) Receives Consensus Rating of "Hold" from Analysts2 hours agoTourmaline Bio, Inc. (NASDAQ:TRML) Given Average Rating of "Buy" by AnalystsMarketBeatTourmaline Bio, Inc. (NASDAQ:TRML - Get Free Report) has earned an average rating of "Buy" from the seven analysts that are currently covering the firm, Marketbeat Ratings reports. Seven investment analysts have rated the stock with a buy rating. The average twelve-month price objective among analNASDAQ:TRMLRead Tourmaline Bio, Inc. (NASDAQ:TRML) Given Average Rating of "Buy" by Analysts2 hours agoAZZ Inc. (NYSE:AZZ) Receives Average Rating of "Moderate Buy" from BrokeragesMarketBeatShares of AZZ Inc. (NYSE:AZZ - Get Free Report) have earned an average rating of "Moderate Buy" from the ten ratings firms that are covering the company, MarketBeat.com reports. Three research analysts have rated the stock with a hold recommendation, five have given a buy recommendation and two havNYSE:AZZRead AZZ Inc. (NYSE:AZZ) Receives Average Rating of "Moderate Buy" from Brokerages Trending News1Morgan Stanley Issues Positive Forecast for Lucid Group (NASDAQ:LCID) Stock Price2Jefferies Financial Group Issues Pessimistic Forecast for lululemon athletica (NASDAQ:LULU) Stock Price3First Manhattan CO. LLC. Makes New $985,000 Investment in SoundHound AI, Inc. $SOUN4CoreWeave (NASDAQ:CRWV) Shares Gap Down - Here's Why5Charles Schwab Investment Management Inc. Increases Position in Intuitive Machines, Inc. $LUNR6Perbak Capital Partners LLP Purchases Shares of 42,336 Archer Aviation Inc. $ACHR7AQR Capital Management LLC Buys 476,763 Shares of PayPal Holdings, Inc. $PYPL8TMC the metals company Inc. $TMC Shares Sold by First Manhattan CO. LLC. All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Dividend Earnings Earnings Preview Estimates Guidance Insider Trade Lockup Expiration Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoSangamo Therapeutics, Inc. (NASDAQ:SGMO) Given Consensus Rating of "Moderate Buy" by AnalystsMarketBeatNASDAQ:SGMORead Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Given Consensus Rating of "Moderate Buy" by Analysts2 hours agoChampion Iron Limited (TSE:CIA) Given Consensus Recommendation of "Buy" by BrokeragesMarketBeatTSE:CIARead Champion Iron Limited (TSE:CIA) Given Consensus Recommendation of "Buy" by Brokerages2 hours agoL'Oreal SA (OTCMKTS:LRLCY) Given Consensus Rating of "Hold" by AnalystsMarketBeatOTCMKTS:LRLCYRead L'Oreal SA (OTCMKTS:LRLCY) Given Consensus Rating of "Hold" by Analysts2 hours agoNabors Industries Ltd. (NYSE:NBR) Given Average Rating of "Reduce" by BrokeragesMarketBeatNYSE:NBRRead Nabors Industries Ltd. (NYSE:NBR) Given Average Rating of "Reduce" by Brokerages2 hours agoStandex International Corporation (NYSE:SXI) Given Average Recommendation of "Buy" by AnalystsMarketBeatNYSE:SXIRead Standex International Corporation (NYSE:SXI) Given Average Recommendation of "Buy" by Analysts2 hours agoPHINIA Inc. (NYSE:PHIN) Receives Consensus Recommendation of "Moderate Buy" from AnalystsMarketBeatNYSE:PHINRead PHINIA Inc. (NYSE:PHIN) Receives Consensus Recommendation of "Moderate Buy" from Analysts2 hours agoBlackSky Technology Inc. (NYSE:BKSY) Receives Consensus Recommendation of "Buy" from AnalystsMarketBeatNYSE:BKSYRead BlackSky Technology Inc. (NYSE:BKSY) Receives Consensus Recommendation of "Buy" from Analysts2 hours agoMBX Biosciences, Inc. (NYSE:MBX) Given Consensus Rating of "Buy" by BrokeragesMarketBeatNYSE:MBXRead MBX Biosciences, Inc. (NYSE:MBX) Given Consensus Rating of "Buy" by Brokerages2 hours agoPet Valu Holdings Ltd. (TSE:PET) Given Consensus Recommendation of "Buy" by BrokeragesMarketBeatTSE:PETRead Pet Valu Holdings Ltd. (TSE:PET) Given Consensus Recommendation of "Buy" by Brokerages2 hours agoIridium Communications Inc (NASDAQ:IRDM) Receives Consensus Rating of "Buy" from AnalystsMarketBeatNASDAQ:IRDMRead Iridium Communications Inc (NASDAQ:IRDM) Receives Consensus Rating of "Buy" from Analysts2 hours agoAdaptive Biotechnologies Corporation (NASDAQ:ADPT) Given Average Recommendation of "Moderate Buy" by AnalystsMarketBeatNASDAQ:ADPTRead Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Given Average Recommendation of "Moderate Buy" by Analysts2 hours agoSouthwest Gas Corporation (NYSE:SWX) Receives Average Recommendation of "Moderate Buy" from AnalystsMarketBeatNYSE:SWXRead Southwest Gas Corporation (NYSE:SWX) Receives Average Recommendation of "Moderate Buy" from Analysts2 hours agoTuHURA Biosciences, Inc. (NASDAQ:HURA) Given Average Rating of "Buy" by AnalystsMarketBeatNASDAQ:HURARead TuHURA Biosciences, Inc. (NASDAQ:HURA) Given Average Rating of "Buy" by Analysts2 hours agoBackblaze, Inc. (NASDAQ:BLZE) Given Consensus Recommendation of "Buy" by BrokeragesMarketBeatNASDAQ:BLZERead Backblaze, Inc. (NASDAQ:BLZE) Given Consensus Recommendation of "Buy" by Brokerages2 hours agoCapital Southwest Corporation (NASDAQ:CSWC) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesMarketBeatNASDAQ:CSWCRead Capital Southwest Corporation (NASDAQ:CSWC) Receives Consensus Recommendation of "Moderate Buy" from Brokerages2 hours agoBitFuFu Inc. (NASDAQ:FUFU) Given Consensus Rating of "Moderate Buy" by BrokeragesMarketBeatNASDAQ:FUFURead BitFuFu Inc. (NASDAQ:FUFU) Given Consensus Rating of "Moderate Buy" by Brokerages2 hours agoCompagnie de Saint-Gobain - Unsponsored ADR (OTCMKTS:CODYY) Receives Average Rating of "Moderate Buy" from BrokeragesMarketBeatOTCMKTS:CODYYRead Compagnie de Saint-Gobain - Unsponsored ADR (OTCMKTS:CODYY) Receives Average Rating of "Moderate Buy" from Brokerages2 hours agoMedexus Pharmaceuticals Inc. (TSE:MDP) Given Consensus Recommendation of "Buy" by BrokeragesMarketBeatTSE:MDPRead Medexus Pharmaceuticals Inc. (TSE:MDP) Given Consensus Recommendation of "Buy" by Brokerages2 hours agoChevron Corporation (NYSE:CVX) Given Consensus Recommendation of "Hold" by BrokeragesMarketBeatNYSE:CVXRead Chevron Corporation (NYSE:CVX) Given Consensus Recommendation of "Hold" by Brokerages2 hours agoEli Lilly and Company (NYSE:LLY) Given Consensus Rating of "Moderate Buy" by AnalystsMarketBeatNYSE:LLYRead Eli Lilly and Company (NYSE:LLY) Given Consensus Rating of "Moderate Buy" by Analysts2 hours agoGeneDx Holdings Corp. (NASDAQ:WGS) Given Average Recommendation of "Moderate Buy" by AnalystsMarketBeatNASDAQ:WGSRead GeneDx Holdings Corp. (NASDAQ:WGS) Given Average Recommendation of "Moderate Buy" by Analysts2 hours agoCG Oncology, Inc. (NASDAQ:CGON) Receives Consensus Recommendation of "Moderate Buy" from AnalystsMarketBeatNASDAQ:CGONRead CG Oncology, Inc. (NASDAQ:CGON) Receives Consensus Recommendation of "Moderate Buy" from Analysts2 hours agoBenitec Biopharma Limited (NASDAQ:BNTC) Given Average Rating of "Buy" by AnalystsMarketBeatNASDAQ:BNTCRead Benitec Biopharma Limited (NASDAQ:BNTC) Given Average Rating of "Buy" by Analysts2 hours agoVeracyte, Inc. (NASDAQ:VCYT) Receives Average Recommendation of "Moderate Buy" from AnalystsMarketBeatNASDAQ:VCYTRead Veracyte, Inc. (NASDAQ:VCYT) Receives Average Recommendation of "Moderate Buy" from Analysts Featured Articles and OffersJoby Aviation's Pullback: A Gift for Investors Who See the FutureBy Jeffrey Neal Johnson | September 2, 2025What Steve Bannon revealed about Trump’s gold playFrom Reagan Gold Group (Ad)Top 5 September Stock Picks: Market Tailwinds Drive New MomentumBy Thomas Hughes | September 1, 2025Morgan Stanley Issues Positive Forecast for Lucid Group (NASDAQ:LCID) Stock PriceBy MarketBeat | September 6, 2025Jefferies Financial Group Issues Pessimistic Forecast for lululemon athletica (NASDAQ:LULU) Stock PriceBy MarketBeat | September 7, 2025Nvidia Times 1,000,000From Paradigm Press (Ad)3 Tariff-Proof Retailers Making New All-time HighsBy Dan Schmidt | September 1, 20253 Healthcare Pathbreakers With Long-Term TailwindsBy Nathan Reiff | September 1, 2025 Sector NewsAerospace NewsArtificial Intelligence NewsAutomotive NewsConsumer Product NewsEnergy NewsFinancial Services NewsHealthcare NewsIndustrial NewsMedia NewsManufacturing NewsTechnology NewsTransportation NewsRetail News Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
